In our study, we showed that leptin levels and leptin–adiponectin ratios were significantly increased and adiponectin levels significantly decreased in patients with schizophrenia with MetS in comparison to patients without MetS. The gene discussed is ADIPOQ; the disease is metabolic syndrome.